Alerts will be sent to your verified email
Verify EmailNGLFINE
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
NGL Fine-Chem Ltd specializes in manufacturing pharmaceuticals and intermediates for veterinary and human health, providing high-quality customizable solutions to global companies.
NGL Fine-Chem major competitors are Hikal, Sequent Scientific, Nectar Lifesciences, Kopran, Shree Ganesh Remed., SMS Lifesciences, Everest Organics.
Market Cap of NGL Fine-Chem is ₹712 Crs.
While the median market cap of its peers are ₹932 Crs.
NGL Fine-Chem seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Mar Jun Sep Dec | ||||||||||||||
Conference Call | Mar Sep | Mar Sep | Mar Jun Sep | Jun Sep Dec | Mar Sep | Dec | ||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|